Thomas Jensen
12Patents
4h-index
32Co-inventors
52Inventor score
Filing activity: Feb 19, 2015 → Sep 14, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9353084B2 | 2-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's disease | Chemistry; Metallurgy | 7 | Active |
| US10647762B2 | Antibodies specific for hyperphosphorylated tau and methods of use thereof | Physics | 5 | Active |
| US10487142B2 | Antibodies specific for hyperphosphorylated tau and methods of use thereof | Physics | 5 | Active |
| US10472415B2 | Antibodies specific for hyperphosphorylated tau and methods of use | Physics | 5 | Active |
| US11111290B2 | Antibodies specific for hyperphosphorylated tau and methods of use thereof | Physics | 4 | Active |
| US11780851B2 | LRRK2 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10004738B2 | Combination treatment comprising administration of 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines | Human Necessities | 1 | Active |
| US9642849B2 | Nalmefene for reduction of alcohol consumption in specific target populations | Human Necessities | 1 | Active |
| US10034874B2 | Nalmefene for reduction of alcohol consumption in specific target populations | Human Necessities | 0 | Active |
| US11958865B1 | Leucine-rich repeat kinase 2 (LRRK2) inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12129289B2 | Antibodies specific for hyperphosphorylated tau and methods of use thereof | Physics | 0 | Active |
| US11993612B2 | LRRK2 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.